sodium ascorbateWhat was measured
Measured, not recorded
- Compound
- sodium ascorbate
- Endpoints measured
- 129 endpoints
- Recorded as a finding
- No
Show what was measured
FIA-induced writhing reaction
decreases
The induction of the writhing reaction was also inhibited by intravenous preadministration of sodium ascorbate (SAs) in saline
PMID:10077427 · one of two readings recorded this
FIA-induced writhing reaction
decreases
The FIA emulsion-induced writhing reaction was found to be remarkably inhibited by preadministration of oral indomethacin, a non-steroidal anti-inflammatory and analgesic drug
PMID:10077427 · one of two readings recorded this
Freund's incomplete adjuvant-induced writhing reaction in mice
decreases
Not recorded as a finding: this platform holds no node for the endpoint
The induction of the writhing reaction was also inhibited by intravenous preadministration of sodium ascorbate (SAs) in saline.
PMID:10077427 · both readings recorded this
writhing reaction induced by FIA+SAs emulsion
decreases
Furthermore, this writhing reaction induced by FIA+SAs emulsion was also inhibited by preadministraion of SAs itself as well as indomethacin
PMID:10077427 · one of two readings recorded this
writhing reaction when sodium ascorbate added to FIA, higher concentrations
increases
At lower concentrations SAs functioned as a suppressor of the writhing reaction, while at concentrations higher than about 1 mg/50 microl/mouse it acted as an enhancer of the reaction
PMID:10077427 · one of two readings recorded this
writhing reaction when sodium ascorbate added to FIA, lower concentrations
decreases
At lower concentrations SAs functioned as a suppressor of the writhing reaction, while at concentrations higher than about 1 mg/50 microl/mouse it acted as an enhancer of the reaction
PMID:10077427 · one of two readings recorded this
ascorbate concentration in plasma and SVCT1-predominant tissues
increases
Compared with males, females had lower ascorbate excretion and ascorbate:creatinine ratio in urine and had higher ascorbate concentrations in plasma and SVCT1-predominant tissues
PMID:15333707 · one of two readings recorded this
hepatic gulonolactone oxidase mRNA and activity
no effect
Hepatic gulonolactone oxidase mRNA and activity levels did not differ with genotype or gender, indicating no differences in ascorbate synthesis
PMID:15333707 · one of two readings recorded this
spleen ascorbate concentration, male vs female
increases
SVCT2 contributed to a gender effect in spleen because males had higher spleen ascorbate concentration than females in wild-type but not in Slc23a2+/- mice
PMID:15333707 · one of two readings recorded this
SVCT1 expression and ascorbate concentration in SVCT1-predominant organs
no effect
The SVCT isoforms appear to function independently of one another because SVCT1 expression and ascorbate concentrations in SVCT1-predominant organs were not affected by SVCT2 deficiency
PMID:15333707 · one of two readings recorded this
SVCT2 mRNA level
decreases
Slc23a2+/- mice had low SVCT2 but normal SVCT1 messenger RNA (mRNA) levels, which did not differ between genders
PMID:15333707 · one of two readings recorded this
tissue ascorbate concentration in SVCT2-predominant tissues
decreases
Ascorbate concentrations were lower in Slc23a2+/- than Slc23a2+/+ mice in tissues where SVCT2 was the main isoform
PMID:15333707 · one of two readings recorded this
urinary ascorbate excretion and ascorbate:creatinine ratio
decreases
Compared with males, females had lower ascorbate excretion and ascorbate:creatinine ratio in urine and had higher ascorbate concentrations in plasma and SVCT1-predominant tissues
PMID:15333707 · one of two readings recorded this
MDC viability under H2O2 stress
increases
we found that the viability of MDCs exposed to a cytotoxic concentration of H2O2 was higher after preincubation with 0.1 mM ASC (2.6-fold), 10 ng/ml bFGF (2.9-fold), or 20 ng/ml bFGF (3.5-fold) than that after exposure to H2O2 only
PMID:17219780 · one of two readings recorded this
MDC viability under H2O2 stress
increases
we found that the viability of MDCs exposed to a cytotoxic concentration of H2O2 was higher after preincubation with 0.1 mM ASC (2.6-fold), 10 ng/ml bFGF (2.9-fold), or 20 ng/ml bFGF (3.5-fold) than that after exposure to H2O2 only
PMID:17219780 · one of two readings recorded this
MDC viability under H2O2 stress
increases
we found that the viability of MDCs exposed to a cytotoxic concentration of H2O2 was higher after preincubation with 0.1 mM ASC (2.6-fold), 10 ng/ml bFGF (2.9-fold), or 20 ng/ml bFGF (3.5-fold) than that after exposure to H2O2 only
PMID:17219780 · one of two readings recorded this
viability of rat muscle-derived cells exposed to a cytotoxic concentration of H2O2 after 24-h preincubation
increases, 2.6-fold higher viability with 0.1 mM ASC than H2O2 only
Not recorded as a finding: this platform holds no node for the endpoint
In addition, we found that the viability of MDCs exposed to a cytotoxic concentration of H2O2 was higher after preincubation with 0.1 mM ASC (2.6-fold), 10 ng/ml bFGF (2.9-fold), or 20 ng/ml bFGF (3.5-fold) than that after exposure to H2O2 only.
PMID:17219780 · both readings recorded this
CD71 (transferrin receptor) cell-surface expression on neuroblastoma cells
decreases
Not recorded as a finding: expression readout, not receptor/enzyme activity; no mechanism predicate applies, and no outcome node exists for receptor expression
Sodium ascorbate decreased the expression of CD71 and caused cell death within 24 h.
PMID:17760959 · one of two readings recorded this
cell survival (trypan blue exclusion, EC50)
decreases, EC50 < 2 mM in all five cell lines
Vitamin C concentrations causing a 50% decrease in cell survival after 24 hours (EC50 values, table 1) were less than 2 mM for all five cell lines, as assessed by trypan blue exclusion method.
PMID:17760959 · one of two readings recorded this
intracellular iron level
decreases
As shown in fig. vitamin C significantly reduced intracellular iron levels in a dose-dependent manner.
PMID:17760959 · one of two readings recorded this
mitochondrial transmembrane potential
decreases
Treatment with vitamin C induced depolarization of the mitochondrial transmembrane potential in all neuroblastoma cell lines investigated (fig., panel A2, A4, panel B2, B4).
PMID:17760959 · one of two readings recorded this
transferrin receptor (CD71) surface expression
decreases
Sodium ascorbate decreased the expression of CD71 and caused cell death within 24 h.
PMID:17760959 · one of two readings recorded this
adhesive failure mode, all-in-one vs two-step
increases, p = 0.015
All-in-one groups had significantly more adhesive failures than two-step adhesive groups (p=0.015)
PMID:23713808 · one of two readings recorded this
adhesive failure, pulp horn vs peripheral position
increases, p = 0.004
The odds of adhesive failure were higher at the pulp horn position than the peripheral position (p=0.004)
PMID:23713808 · one of two readings recorded this
microshear bond strength and failure mode after sodium perborate bleaching
no effect
Sodium perborate bleaching of dentin had no effect on MSBS or mode of failure for either two-step or all-in-one self-etching adhesives
PMID:23713808 · one of two readings recorded this
microshear bond strength, between treatment groups
no effect
There were no significant differences between the treatment types/groups
PMID:23713808 · one of two readings recorded this
microshear bond strength, center and pulp horn vs peripheral
decreases, p = 0.001
For the all-in-one adhesive, MSBSs at the center and pulp horn positions were significantly lower than the peripheral positions (p<0.001)
PMID:23713808 · one of two readings recorded this
microshear bond strength (MSBS) of resin composite to sodium perborate-bleached dentin
no effect
Not recorded as a finding: this platform holds no node for the endpoint
There were no significant differences between the treatment types/groups.
PMID:23713808 · both readings recorded this
microshear bond strength, two-step vs all-in-one adhesive
increases, p = 0.028
MSBSs were significantly higher for two-step self-etching adhesive compared with all-in-one self-etching adhesive (p=0.028)
PMID:23713808 · one of two readings recorded this
hybrid layer and resin tag formation and microtensile bond strength
decreases
Tooth bleaching with CP or HP impairs the formation of the hybrid layer and resin tags and reduces the microtensile bond strength
PMID:23848067 · one of two readings recorded this
hybrid layer + tag formation
increases
hybrid layer + tag formation (in micrometers) were G C, 13.27 Aa; G SA, 11.85 Ba; G CP, 6.84 Bb; G CP+SA, 9.02 Ab; G HP, 7.28 Bb; and G HP+SA, 9.22 Ab
PMID:23848067 · one of two readings recorded this
hybrid layer thickness and resin tag length by optic microscopy; microtensile bond strength to dentin (MPa)
increases
Not recorded as a finding: this platform holds no node for the endpoint
Statistically, the use of SA significantly increases the hybrid layer thickness and resin tag length.
PMID:23848067 · one of two readings recorded this
hybrid layer thickness and resin tag length of bleached dentin, optic microscopy after Brown & Brenn staining
increases
Not recorded as a finding: this platform holds no node for the endpoint
Statistically, the use of SA significantly increases the hybrid layer thickness and resin tag length.
PMID:23848067 · one of two readings recorded this
hybrid layer thickness and resin tag length
increases
Statistically, the use of SA significantly increases the hybrid layer thickness and resin tag length
PMID:23848067 · one of two readings recorded this
microtensile bond strength, hydrogen peroxide-bleached
no effect
The microtensile bond strength values for carbamide peroxide increased, but the microtensile bond strength for hydrogen peroxide was not affected
PMID:23848067 · one of two readings recorded this
microtensile bond strength
modulates
bond strength results (in MPa) were G C, 49.5 Aa; G SA, 51.7 Aa; G CP, 37.16 Bb; G CP+SA, 47.69 Aa; G HP, 32.39 Ab; and G HP+SA, 39.67 Ab
PMID:23848067 · one of two readings recorded this
elastase, protease and haemolysin virulence factor activities
decreases
The influence of sub-MIC of sodium ascorbate on virulence factors was also determined and ascorbate treatment led to significant depression of elastase, protease and haemolysin activities.
PMID:25175797 · one of two readings recorded this
expression of QS regulatory genes lasI, lasR, rhlI, rhlR, pqsR and pqsA
Not recorded as a finding: sentence reports gene expression was repressed 'compared to untreated' PAO1 without naming sodium ascorbate as the acting agent in the same clause, so the quote does not self-support the claim
Expression of QS regulatory genes, lasI, lasR, rhlI, rhlR, pqsR and pqsA, was repressed compared to untreated Ps. aeruginosa PAO1, confirming that ascorbate QS inhibition works on gene expression at the molecular level.
PMID:25175797 · one of two readings recorded this
expression of QS regulatory genes (lasI, lasR, rhlI, rhlR, pqsR, pqsA)
Expression of QS regulatory genes, lasI, lasR, rhlI, rhlR, pqsR and pqsA, was repressed compared to untreated Ps. aeruginosa PAO1, confirming that ascorbate QS inhibition works on gene expression at the molecular level.
PMID:25175797 · one of two readings recorded this
expression of quorum-sensing regulatory genes lasI, lasR, rhlI, rhlR, pqsR and pqsA in Pseudomonas aeruginosa PAO1
decreases
Not recorded as a finding: six genes reported as one repressed group with no single-gene object span, and transcript-level gene expression is not a mechanism_claims predicate (inhibits/activates describe protein activity, not expression)
Expression of QS regulatory genes, lasI, lasR, rhlI, rhlR, pqsR and pqsA, was repressed compared to untreated Ps. aeruginosa PAO1, confirming that ascorbate QS inhibition works on gene expression at the molecular level.
PMID:25175797 · one of two readings recorded this
expression of quorum-sensing regulatory genes lasI, lasR, rhlI, rhlR, pqsR and pqsA
decreases
Expression of QS regulatory genes, lasI, lasR, rhlI, rhlR, pqsR and pqsA, was repressed compared to untreated Ps. aeruginosa PAO1, confirming that ascorbate QS inhibition works on gene expression at the molecular level.
PMID:25175797 · one of two readings recorded this
pyocyanin production, biofilm formation, and motility of Pseudomonas aeruginosa PAO1
Not recorded as a finding: reported as one agentless-passive clause covering three distinct virulence phenotypes with mixed/unstated direction on motility, not anchorable to a single named protein or compound object for mechanism_claims
In addition, inhibition of pyocyanin production, attenuation of biofilm formation and alteration of Pseudomonas motility was observed.
PMID:25175797 · one of two readings recorded this
pyocyanin production, biofilm formation and Pseudomonas motility
Not recorded as a finding: sentence reporting this finding is an agentless passive ('was observed') that does not name sodium ascorbate as the acting agent, so it cannot anchor a claim on its own
In addition, inhibition of pyocyanin production, attenuation of biofilm formation and alteration of Pseudomonas motility was observed.
PMID:25175797 · one of two readings recorded this
pyocyanin production, biofilm formation, and Pseudomonas motility
In addition, inhibition of pyocyanin production, attenuation of biofilm formation and alteration of Pseudomonas motility was observed.
PMID:25175797 · one of two readings recorded this
quorum sensing signalling molecule concentration (C4-HSL, 3-oxo-C12-HSL)
decreases
Sub-MICs of sodium ascorbate resulted in significant reduction of the signalling molecules C4-HSL and 3-oxo-C12-HSL (P < 0·01).
PMID:25175797 · one of two readings recorded this
signalling molecules C4-HSL and 3-oxo-C12-HSL concentration, reporter strain assay
decreases
Sub-MICs of sodium ascorbate resulted in significant reduction of the signalling molecules C4-HSL and 3-oxo-C12-HSL (P < 0·01).
PMID:25175797 · one of two readings recorded this
virulence factor activity (elastase, protease, haemolysin)
decreases
The influence of sub-MIC of sodium ascorbate on virulence factors was also determined and ascorbate treatment led to significant depression of elastase, protease and haemolysin activities.
PMID:25175797 · one of two readings recorded this
BL6 melanoma growth in vivo
decreases
Supplementary dietary ascorbate increased liver and tumor ascorbic acid levels and also reduced the growth of BL6 melanomas transplanted in C57 mice
PMID:2703917 · one of two readings recorded this
cellular ascorbic acid levels, BL6 versus LLCMK cells
no effect
Ascorbic acid levels in both cell types were very similar
PMID:2703917 · one of two readings recorded this
growth of BL6 melanomas transplanted in C57 mice, and in vitro growth of BL6 and LLCMK cells
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Supplementary dietary ascorbate increased liver and tumor ascorbic acid levels and also reduced the growth of BL6 melanomas transplanted in C57 mice.
PMID:2703917 · one of two readings recorded this
growth of BL6 melanomas transplanted in C57 mice; in vitro growth of BL6 and LLCMK cells; liver and tumor ascorbic acid levels
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Supplementary dietary ascorbate increased liver and tumor ascorbic acid levels and also reduced the growth of BL6 melanomas transplanted in C57 mice.
PMID:2703917 · one of two readings recorded this
in vitro cell growth
decreases
Ascorbate addition at levels of up to 200 micrograms/ml was found to inhibit the in vitro growth of BL6 cells but not of LLCMK cells
PMID:2703917 · one of two readings recorded this
in vitro cell growth
no effect
Ascorbate addition at levels of up to 200 micrograms/ml was found to inhibit the in vitro growth of BL6 cells but not of LLCMK cells
PMID:2703917 · one of two readings recorded this
liver ascorbic acid level
decreases
The presence of tumors was found to reduce liver ascorbic acid levels in mice
PMID:2703917 · one of two readings recorded this
liver ascorbic acid level
increases
Supplementary dietary ascorbate increased liver and tumor ascorbic acid levels and also reduced the growth of BL6 melanomas transplanted in C57 mice
PMID:2703917 · one of two readings recorded this
tumor ascorbic acid level
increases
Supplementary dietary ascorbate increased liver and tumor ascorbic acid levels and also reduced the growth of BL6 melanomas transplanted in C57 mice
PMID:2703917 · one of two readings recorded this
cytotoxic effect of methotrexate and DTIC on neuroblastoma cells
decreases
Sodium L-ascorbate did not enhance the effect of vincristine, 6-thioguanine, or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) except at higher drug doses and it reduced the cytotoxic effect of methotrexate and 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) on NB cells.
PMID:284405 · one of two readings recorded this
growth inhibition (cell death and reduced division) of neuroblastoma vs glioma cells
increases
Sodium L-ascorbate at nonlethal concentrations potentiated the effect of 5-fluorouracil (FUra), x-irradiation, bleomycin, RO20-1724, prostaglandin E1, and sodium butyrate on NB cells but did not produce such an effect on glioma cells.
PMID:284405 · one of two readings recorded this
dentin surface crystal deposition (SEM/EDS)
increases
The portion of the dentin surface filled with the crystals and the size of crystal increased in the dentin surface after 72 hours of application time of 10% SA solution.
PMID:29109820 · one of two readings recorded this
microtensile bond strength (µTBS, MPa) of composite resin to bleached dentin at varying sodium ascorbate application times
no effect
Not recorded as a finding: this platform holds no node for the endpoint
No significant difference was observed among the control group and subgroups DB, SA 5 m, SA 10 m, SA 30 m, SA 1 h, SA 24 h, and SA 48 h (p > 0.05).
PMID:29109820 · one of two readings recorded this
microtensile bond strength (µTBS) of composite resin to bleached dentin
no effect
No significant difference was observed among the control group and subgroups DB, SA 5 m, SA 10 m, SA 30 m, SA 1 h, SA 24 h, and SA 48 h (p > 0.05).
PMID:29109820 · one of two readings recorded this
pushout bond strength (MPa) of a fiber post luted to radicular dentin after irrigation with 10% sodium ascorbate versus other collagen cross-linkers
increases, n = 28
Not recorded as a finding: this platform holds no node for the endpoint
There was a significant increase in the mean push out bond strength as compared to Group 1 (control group) (P < 0.001).
PMID:29628656 · one of two readings recorded this
pushout bond strength of fiber post luted to radicular dentin after irrigation with 10% sodium ascorbate, 10% hesperidin, 1% riboflavin 5-phosphate or normal saline, by Universal Testing Machine
increases
Not recorded as a finding: this platform holds no node for the endpoint
All collagen cross-linkers so used, increased the bond strength.
PMID:29628656 · one of two readings recorded this
pushout bond strength of fiber post to radicular dentin
increases, n = 28
There was a significant increase in the mean push out bond strength as compared to Group 1 (control group) (P < 0.001).
PMID:29628656 · one of two readings recorded this
antibody structural integrity (SDS-PAGE/autoradiography)
increases
These findings suggest that 211At‐anti‐TF mAb in PBS was disrupted by the radionuclide, and 0.6% and 1.2% SA protected the immunoconjugates from antibody denaturation.
PMID:33606344 · one of two readings recorded this
antitumor activity of 211At-labeled anti-tissue factor antibody in a high TF-expressing gastric cancer xenograft model
increases
Not recorded as a finding: the compound was a reagent, not an exposure
In a high TF-expressing gastric cancer xenograft model, 211 At-anti-TF mAb in 1.2% SA exerted a significantly greater antitumor effect than nonprotected 211 At-anti-TF mAb.
PMID:33606344 · one of two readings recorded this
antitumor effect in gastric cancer xenografts (tumour volume)
increases, p = 0.0045
In the 44As3 xenograft model with high TF expression, 211At‐anti‐TF mAb eluted in PBS containing 1.2% SA exerted a significantly greater antitumor effect than the astatinated anti‐TF mAb in PBS (P =.0045).
PMID:33606344 · one of two readings recorded this
body weight loss (toxicity)
no effect, 5.65 ± 1.39% at 2 days, transient
Although relative body weight loss reached 5.65 ± 1.39% at 2 days after administration of 1.2% SA in PBS, the loss was transient.
PMID:33606344 · one of two readings recorded this
adult mosquito mortality
unclear
Four of the six volatile compounds increased mortality in at least one species.
PMID:35861727 · one of two readings recorded this
mosquito feeding/attraction to the bait
increases
Addition of anisaldehyde also significantly increased An. stephensi feeding rates on the SA-ATSB, though mosquitoes will avoid the toxic bait if a nontoxic sugar source is available.
PMID:35861727 · one of two readings recorded this
colour change (ΔEab, ΔE00, ΔWID) of bleached teeth after sodium ascorbate application
decreases
Not recorded as a finding: no outcome node exists for post-bleaching tooth colour change
Application of 10% SA after in-office bleaching successfully reduced the penetration of HP into the pulp chamber; however, it decreased color change.
PMID:38133477 · one of two readings recorded this
microtensile bond strength (µTBS) to resin-enamel interface
decreases
However, significantly lower µTBS values (p < 0.00001) were obtained in the SA group than in the control and NSA groups (Table 3).
PMID:38133477 · one of two readings recorded this
microtensile bond strength (µTBS) to the resin-enamel interface after sodium ascorbate application post-bleaching
increases
Not recorded as a finding: no outcome node exists for dental resin-enamel microtensile bond strength
SA application significantly improved the µTBS values and reduced the HP concentrations within the pulp chambers (p < 0.0001).
PMID:38133477 · one of two readings recorded this
tooth colour change (ΔEab, ΔE00, ΔWID)
decreases
However, significant and lower color changes (p > 0.07) for all measurements (ΔEab, ΔE00, and ΔWiD) were observed for the SA group (Table 2).
PMID:38133477 · one of two readings recorded this
cerebral cortical temperature, implanted frontal cortex combination sensor
decreases, 39.2 [0.1]°C, restored from septic hyperthermia
Not recorded as a finding: CAT:outcome/core-body-temperature requires a rectal, oesophageal or ingestible telemetric CORE-site probe; this study measured cerebral cortex temperature via an implanted frontal cortex sensor, a different site — endpoint_near_miss, not a match
Sodium ascorbate restored cerebral perfusion (703 [121] units], oxygenation (30 [2] mm Hg), temperature (39.2 [0.1]°C) (all PTreatment<0.05), and the behavioural state to normal.
PMID:38960833 · one of two readings recorded this
cerebral cortical tissue oxygenation, oxygen-sensing probe
increases, (30 [2] mm Hg)
Not recorded as a finding: no outcome node exists for cerebral tissue oxygenation
Sodium ascorbate restored cerebral perfusion (703 [121] units], oxygenation (30 [2] mm Hg), temperature (39.2 [0.1]°C) (all PTreatment<0.05), and the behavioural state to normal.
PMID:38960833 · one of two readings recorded this
cerebral cortical tissue perfusion and oxygenation, implanted frontal cortex probe
increases, perfusion 703 [121] units; oxygenation 30 [2] mm Hg
Not recorded as a finding: no outcome node exists for cerebral cortical tissue perfusion or brain tissue oxygenation
Sodium ascorbate restored cerebral perfusion (703 [121] units], oxygenation (30 [2] mm Hg), temperature (39.2 [0.1]°C) (all PTreatment<0.05), and the behavioural state to normal.
PMID:38960833 · one of two readings recorded this
cerebral cortical tissue perfusion, combination sensor in frontal cerebral cortex
increases, (703 [121] units)
Not recorded as a finding: no outcome node exists for cerebral tissue perfusion
Sodium ascorbate restored cerebral perfusion (703 [121] units], oxygenation (30 [2] mm Hg), temperature (39.2 [0.1]°C) (all PTreatment<0.05), and the behavioural state to normal.
PMID:38960833 · one of two readings recorded this
cerebral cortical tissue perfusion, oxygenation and temperature, and plasma interleukin-6, VEGF-A and ascorbate concentrations in ovine Gram-negative sepsis
increases, cerebral perfusion 703 [121] units, oxygenation 30 [2] mmHg, temperature 39.2 [0.1]°C
Not recorded as a finding: this platform holds no node for the endpoint
Sodium ascorbate restored cerebral perfusion (703 [121] units], oxygenation (30 [2] mm Hg), temperature (39.2 [0.1]°C) (all PTreatment<0.05), and the behavioural state to normal.
PMID:38960833 · one of two readings recorded this
cerebral cortical tissue temperature, combination sensor in frontal cerebral cortex
decreases, (39.2 [0.1]°C, restored from a sepsis-induced hyperthermia of 40.8 [0.1]°C)
Not recorded as a finding: the core-body-temperature node requires a rectal, oesophageal, or ingestible telemetric-pill site; this study measured temperature with an intracranial frontal-cortex tissue probe, a different site the node does not cover (endpoint_near_miss)
Sodium ascorbate restored cerebral perfusion (703 [121] units], oxygenation (30 [2] mm Hg), temperature (39.2 [0.1]°C) (all PTreatment<0.05), and the behavioural state to normal.
PMID:38960833 · one of two readings recorded this
cerebral tissue perfusion, oxygenation and temperature
increases, perfusion 703 [121] units, oxygenation 30 [2] mmHg, temperature 39.2 [0.1]°C, n = 12
Sodium ascorbate restored cerebral perfusion (703 [121] units], oxygenation (30 [2] mm Hg), temperature (39.2 [0.1]°C) (all PTreatment<0.05), and the behavioural state to normal.
PMID:38960833 · one of two readings recorded this
plasma interleukin-6 and VEGF-A
decreases
Sodium ascorbate slightly reduced the sepsis-induced increase in interleukin-6, returned VEGF-A to normal (both PGroupxTime<0.01), and increased plasma ascorbate (20 000 [300] μM; PGroup<0.001).
PMID:38960833 · one of two readings recorded this
plasma VEGF-A concentration
Not recorded as a finding: no outcome node exists for VEGF-A
Sodium ascorbate slightly reduced the sepsis-induced increase in interleukin-6, returned VEGF-A to normal (both PGroupxTime<0.01), and increased plasma ascorbate (20 000 [300] μM; PGroup<0.001).
PMID:38960833 · both readings recorded this
sickness behaviour / behavioural state (malaise, lethargy) in septic sheep
decreases
Not recorded as a finding: no outcome node exists for animal sickness-behaviour severity
Sodium ascorbate restored cerebral perfusion (703 [121] units], oxygenation (30 [2] mm Hg), temperature (39.2 [0.1]°C) (all PTreatment<0.05), and the behavioural state to normal.
PMID:38960833 · one of two readings recorded this
biomass and total lipid content of Phaeodactylum tricornutum microalgae following sodium ascorbate antioxidant supplementation
increases, biomass +10%, total lipids +40%
Not recorded as a finding: this platform holds no node for the endpoint
SE treatment increased biomass by 10 % and total lipids by 40 %, especially C16:0 and C16:1 fatty acids.
PMID:40527426 · one of two readings recorded this
biomass and total lipid content
increases, biomass +10%, total lipids +40%
SE treatment increased biomass by 10 % and total lipids by 40 %, especially C16:0 and C16:1 fatty acids.
PMID:40527426 · one of two readings recorded this
cellular ascorbate (vitamin C) content of Phaeodactylum tricornutum
increases
Not recorded as a finding: no mechanism predicate captures raising an endogenous metabolite's concentration (depletes only covers lowering), and no outcome node exists for microalgal ascorbate content
Mechanistically, SE triggered chloroplast ROS accumulation and enhanced antioxidant defenses (higher VC levels and APX/CAT/SOD activities).
PMID:40527426 · one of two readings recorded this
microalgal biomass and total lipid content of Phaeodactylum tricornutum
increases, biomass +10%; total lipids +40%
Not recorded as a finding: no outcome node exists for microalgal biofuel biomass or lipid yield
SE treatment increased biomass by 10 % and total lipids by 40 %, especially C16:0 and C16:1 fatty acids.
PMID:40527426 · one of two readings recorded this
polyunsaturated fatty acid (PUFA) content
decreases
This response reduced PUFAs but increased overall lipid yield.
PMID:40527426 · one of two readings recorded this
cerebral tissue oxygenation and sickness behaviour
increases, 19.9 ± 4.7 to 31.2 ± 1.6 mmHg, p = 0.1
This clinical recovery paralleled normalization of cerebral tissue pO₂ (from 19.9 ± 4.7 mmHg at 23-h to 31.2 ± 1.6 mmHg at 31-h; baseline 35.9 ± 1.6 mmHg, P = 0.10; Fig. 6a–b).
PMID:41457243 · one of two readings recorded this
norepinephrine dose required to maintain MAP ~70 mmHg
decreases, p = 0.007, n = 8
In contrast, 3.0 g/kg sodium ascorbate rapidly reduced norepinephrine requirements to 0.2 ± 0.1 µg/kg/min at 31-h (Ptime*treatment = 0.007), with complete weaning off norepinephrine in 4 of 8 animals.
PMID:41457243 · one of two readings recorded this
norepinephrine (vasopressor) dose required to maintain mean arterial pressure in ovine Gram-negative sepsis
decreases, reduced to 0.2 ± 0.1 µg/kg/min at 31-h with complete weaning in 4 of 8 animals, vs progressive escalation in vehicle and lower-dose groups, p = 0.007, n = 8
Not recorded as a finding: CAT:outcome/time-to-vasopressor-discontinuation requires elapsed time to a stated washout (48 consecutive hours in the trials that defined it); this study reports a titrated infusion dose at a fixed timepoint under an actively controlled MAP target, not a discontinuation time with that washout, so the instrument does not match the node
In contrast, 3.0 g/kg sodium ascorbate rapidly reduced norepinephrine requirements to 0.2 ± 0.1 µg/kg/min at 31-h (Ptime*treatment = 0.007), with complete weaning off norepinephrine in 4 of 8 animals.
PMID:41457243 · one of two readings recorded this
plasma creatinine
decreases
In contrast, all three doses significantly attenuated the rise in plasma creatinine, with levels returning to or below baseline from 1.5 h of treatment (Ptime*treatment < 0.0001, Fig. 3a–b).
PMID:41457243 · one of two readings recorded this
renal medullary tissue oxygen tension
increases, p = 0.006
The highest dose (3.0 g/kg) rapidly reversed renal medullary hypoxia to baseline values, with this effect being sustained throughout the experiment (from 25.2 ± 0.002 at 23-h to 43.4 ± 0.8 mmHg at 31-h, P = 0.006, Fig. 2e, g).
PMID:41457243 · one of two readings recorded this
renal medullary tissue oxygenation and urine flow rate
increases, renal medullary oxygenation 25.2 ± 3.3 to 43.4 ± 4.5 mmHg; urine flow 0.5 ± 0.2 to 6.9 ± 2.4 ml/kg/h
Not recorded as a finding: no outcome node exists for renal medullary oxygenation or urine flow in septic sheep; the two measures share one sentence with distinct p-values so neither is paired here
The improvements in renal medullary oxygenation (25.2 ± 3.3 to 43.4 ± 4.5 mmHg, P = 0.04) and urine flow (from 0.5 ± 0.2 to 6.9 ± 2.4 ml/kg/h, P < 0.0001) were dose-dependent.
PMID:41457243 · one of two readings recorded this
renal medullary tissue oxygenation, oxygen-sensing probe
increases, (25.2 ± 3.3 to 43.4 ± 4.5 mmHg, P = 0.04), p = 0.04
Not recorded as a finding: no outcome node exists for renal medullary tissue oxygenation
The improvements in renal medullary oxygenation (25.2 ± 3.3 to 43.4 ± 4.5 mmHg, P = 0.04) and urine flow (from 0.5 ± 0.2 to 6.9 ± 2.4 ml/kg/h, P < 0.0001) were dose-dependent.
PMID:41457243 · one of two readings recorded this
urine flow rate, ml/kg/h
increases, (from 0.5 ± 0.2 to 6.9 ± 2.4 ml/kg/h, P < 0.0001)
Not recorded as a finding: no outcome node exists for urine output/flow rate
The improvements in renal medullary oxygenation (25.2 ± 3.3 to 43.4 ± 4.5 mmHg, P = 0.04) and urine flow (from 0.5 ± 0.2 to 6.9 ± 2.4 ml/kg/h, P < 0.0001) were dose-dependent.
PMID:41457243 · one of two readings recorded this
urine output
increases, 0.5 ± 0.2 to 6.9 ± 0.8 mL/kg/h
Sodium ascorbate caused a large dose-related increase in urine flow (from 0.5 ± 0.2 at 23-h to 6.9 ± 0.8 ml/kg/h at 31-h in 3.0 g/kg, Ptime*treatment < 0.0001, Fig. 3e, Table 2).
PMID:41457243 · one of two readings recorded this
vasopressor (norepinephrine) requirement to maintain mean arterial pressure
no effect
Not recorded as a finding: no outcome node exists for vasopressor dose/requirement itself, distinct from the MAP node used for the 3.0 g/kg claim; recorded here for the 1.0 and 2.0 g/kg doses, which showed no effect
Lower doses of sodium ascorbate (1.0 and 2.0 g/kg) had no significant effect on vasopressor requirements.
PMID:41457243 · one of two readings recorded this
28-day mortality / death or persistent organ dysfunction (ascorbic acid RCTs, narrated)
increases, unadjusted risk ratio, 1.21; 95% CI, 1.04 to 1.40, p = 0.01, n = 872
There was an increase in the primary outcome of death or persistent organ dysfunction at day 28 in the ascorbic acid group (unadjusted risk ratio, 1.21; 95%CI, 1.04 to 1.40; P = 0.01).
PMID:41485064 · one of two readings recorded this
hospital mortality (single-centre retrospective ascorbic acid + hydrocortisone + thiamine protocol, narrated)
decreases, 8.5% (4/47) vs 40.4% (19/47), n = 94
Hospital mortality (the primary outcome) was 8.5% (4/47) in the treatment group compared to 40.4% (19/47) in the control group (P < 0.001).
PMID:41485064 · one of two readings recorded this
vasopressor requirement and urine output, Phase I sodium ascorbate trial (narrated)
increases, n = 30
Subsequently, a Phase I, double-blind, placebo-controlled trial of IV sodium ascorbate (60 g) in 30 patients with septic shock demonstrated that the intervention was safe and feasible, with early signs of benefit, including increased urine output and reduced vasopressor requirements.
PMID:41485064 · one of two readings recorded this
Clostridium botulinum toxin formation in vacuum-packaged wieners
no effect
Not recorded as a finding: the intervention held more than the compound
Sodium ascorbate at levels of 105 and 655 mug/g of product did not decrease the effectiveness of the sodium nitrite inhibition, nor did sodium ascorbate potentiate it.
PMID:4596392 · one of two readings recorded this
Clostridium botulinum toxin formation in wieners
no effect
Sodium ascorbate at levels of 105 and 655 mug/g of product did not decrease the effectiveness of the sodium nitrite inhibition, nor did sodium ascorbate potentiate it.
PMID:4596392 · one of two readings recorded this
toxin formation by Clostridium botulinum in vacuum-packaged wieners, and the effectiveness of sodium nitrite's inhibition of that toxin formation
no effect
Not recorded as a finding: this platform holds no node for the endpoint
Sodium ascorbate at levels of 105 and 655 mug/g of product did not decrease the effectiveness of the sodium nitrite inhibition, nor did sodium ascorbate potentiate it.
PMID:4596392 · one of two readings recorded this
toxin formation by Clostridium botulinum in vacuum-packaged wieners, assessed for inhibition by sodium nitrite with or without sodium ascorbate
no effect
Not recorded as a finding: this platform holds no node for the endpoint
Sodium ascorbate at levels of 105 and 655 mug/g of product did not decrease the effectiveness of the sodium nitrite inhibition, nor did sodium ascorbate potentiate it.
PMID:4596392 · one of two readings recorded this
calcium phosphate-containing amorphous precipitate in urine
increases
This precipitate was observed in the present experiment in the rats administered the high dose of sodium saccharin or the higher doses of sodium ascorbate
PMID:7586194 · one of two readings recorded this
precipitate formation and urothelial proliferation
decreases
Formation of this precipitate and induction of urothelial proliferation were inhibited by co-administration of NH4Cl, but somewhat higher doses of ammonium chloride were required for doses of sodium ascorbate compared to sodium saccharin
PMID:7586194 · one of two readings recorded this
urinary tract effects (urothelial proliferation)
no effect
The lowest dose, 0.91%, was without effect on the urinary tract
PMID:7586194 · one of two readings recorded this
urothelial hyperplasia and labeling index in the male rat urinary bladder
increases
Not recorded as a finding: this platform holds no node for the endpoint
These results demonstrate that sodium ascorbate administered through the neonatal time period of the male rat produces urothelial hyperplasia in the dose responsive manner, with a no-effect level of 0.91% of the diet.
PMID:7586194 · one of two readings recorded this
urothelial hyperplasia and labeling index
decreases
Sodium saccharin administered as 5% of the diet produced urothelial hyperplasia and increased labeling index, and this was inhibited by co-administration with 1.23% NH4Cl
PMID:7586194 · one of two readings recorded this
urothelial hyperplasia and labeling index
increases
Sodium saccharin administered as 5% of the diet produced urothelial hyperplasia and increased labeling index, and this was inhibited by co-administration with 1.23% NH4Cl
PMID:7586194 · one of two readings recorded this
urothelial proliferative response
no effect
A slight effect (not statistically significant) was observed at a dose of 2.73%, and a significant proliferative response was detected at 4.56 and 6.84%
PMID:7586194 · one of two readings recorded this
urothelial proliferative response
increases
A slight effect (not statistically significant) was observed at a dose of 2.73%, and a significant proliferative response was detected at 4.56 and 6.84%
PMID:7586194 · one of two readings recorded this
urothelial proliferative response
increases
A slight effect (not statistically significant) was observed at a dose of 2.73%, and a significant proliferative response was detected at 4.56 and 6.84%
PMID:7586194 · one of two readings recorded this
cell loss
no effect
Significant cell loss was observed in Molt-4, but not in lymphocyte and fibroblast cultures, after 4 h of incubation in 50 microM of sodium ascorbate, a concentration similar to the plasma level of ascorbic acid in humans
PMID:9202729 · one of two readings recorded this
cell loss
increases
Significant cell loss was observed in Molt-4, but not in lymphocyte and fibroblast cultures, after 4 h of incubation in 50 microM of sodium ascorbate, a concentration similar to the plasma level of ascorbic acid in humans
PMID:9202729 · one of two readings recorded this
DNA single-strand breaks in human lymphocytes, fibroblasts and Molt-4 cells, alkaline microgel electrophoresis
increases
Not recorded as a finding: this platform holds no node for the endpoint
Incubation of human lymphocytes, neonatal fibroblasts, and Molt-4 cells (T-cell leukemia cell line) with sodium ascorbate for 1 h resulted in a concentration-dependent increase in DNA single-strand breaks as assayed by an alkaline microgel electrophoresis technique.
PMID:9202729 · one of two readings recorded this
DNA single-strand breaks in human lymphocytes, fibroblasts and Molt-4 cells by alkaline microgel electrophoresis
increases
Not recorded as a finding: this platform holds no node for the endpoint
Incubation of human lymphocytes, neonatal fibroblasts, and Molt-4 cells (T-cell leukemia cell line) with sodium ascorbate for 1 h resulted in a concentration-dependent increase in DNA single-strand breaks as assayed by an alkaline microgel electrophoresis technique.
PMID:9202729 · one of two readings recorded this
DNA single-strand breaks, sensitivity of fibroblasts and Molt-4 cells relative to lymphocytes
increases
Fibroblasts and Molt-4 cells were significantly more sensitive than lymphocytes to the induction of DNA single-strand breaks by 25, 50, and 100 microM concentrations of sodium ascorbate
PMID:9202729 · one of two readings recorded this
DNA single-strand breaks
increases
Incubation of human lymphocytes, neonatal fibroblasts, and Molt-4 cells (T-cell leukemia cell line) with sodium ascorbate for 1 h resulted in a concentration-dependent increase in DNA single-strand breaks as assayed by an alkaline microgel electrophoresis technique
PMID:9202729 · one of two readings recorded this
cytotoxic activity of sodium ascorbate and dopamine mixed
decreases
When these two compounds were mixed together before adding to HSC-4 cells, both of their cytotoxic activities were diminished
PMID:9870554 · one of two readings recorded this
cytotoxicity of sodium ascorbate and dopamine
decreases
Both of these two compounds dose-dependently reduced the viable cell number of human oral squamous carcinoma HSC-4 cells, and their cytotoxic activity was significantly reduced by catalase
PMID:9870554 · one of two readings recorded this
dopamine radical ESR signal
decreases
Addition of increasing concentrations of sodium ascorbate completely scavenged the dopamine radical and replaced the latter with its own radical
PMID:9870554 · one of two readings recorded this
dopamine radical intensity by ESR, methionine oxidation, hydrogen peroxide generation and viable cell number of HSC-4 cells
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Addition of increasing concentrations of sodium ascorbate completely scavenged the dopamine radical and replaced the latter with its own radical.
PMID:9870554 · one of two readings recorded this
methionine oxidation and hydrogen peroxide generation in culture medium
increases
These two compounds stimulated the methionine oxidation and hydrogen peroxide generation in culture medium, but in combination, their stimulation activities were weakened
PMID:9870554 · one of two readings recorded this
methionine oxidation and hydrogen peroxide generation in culture medium
decreases
These two compounds stimulated the methionine oxidation and hydrogen peroxide generation in culture medium, but in combination, their stimulation activities were weakened
PMID:9870554 · one of two readings recorded this
sodium ascorbate radical intensity
decreases
Similarly, dopamine slightly, but significantly reduced the radical intensity of sodium ascorbate
PMID:9870554 · one of two readings recorded this
viable HSC-4 cell number
decreases
Both of these two compounds dose-dependently reduced the viable cell number of human oral squamous carcinoma HSC-4 cells, and their cytotoxic activity was significantly reduced by catalase
PMID:9870554 · one of two readings recorded this